The Latest Breaking News from FDA

PHILADELPHIA -- The Food and Drug Administration urged food manufacturers last week to significantly reduce the amount of lead in processed baby food.

This month, the Food and Drug Administration approved a new drug, lecanemab, for the treatment of Alzheimer’s disease. The drug, sold under the brand name Leqembi, was developed by Japanese pharmaceutical company Eisai and will be marketed commercially in partnership with American pharmaceutical company Biogen. Biogen, notably, is the maker…

The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.

In recent months, patients have reported problems filling nearly every type of ADHD medication prescription – and no one seems to know why

The Food and Drug Administration has withdrawn its provisional support for the use of Evusheld, a medication that was once a valuable tool for preventing patients with weakened immune systems from becoming severely ill with COVID-19.

The FDA announced a draft of new guidelines Friday that would end mandatory three-month abstinence periods for men who have sex with men. For Illinois hospitals and blood banks, the change is long overdue.

The Food and Drug Administration announced Friday a proposal to ease restrictions on blood donation by gay and bisexual men. The move was celebrated by LGBTQ rights advocates as “a tremendous leap forward toward elevating science over stigma.”

An FDA advisory committee recommended a major overhaul to how COVID shots are issued

Social media users shared a range of false claims this week

Several medical and LGBTQ groups have called the FDA's blood donor restrictions on gay men "discriminatory."

The U.S. is making it easier for gay and bisexual men to give blood by easing restrictions on groups that traditionally face higher risks of HIV